Susquehanna International Group, LLP Acelrx Pharmaceuticals Inc Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021
SELL
$1.03 - $1.7 $64,763 - $106,890
-62,877 Reduced 67.65%
30,063 $41,000
Q1 2021

May 17, 2021
BUY
$1.25 - $2.77 $22,692 - $50,286
18,154 Added 24.27%
92,940 $158,000
Q4 2020

Feb 16, 2021
BUY
$1.18 - $1.98 $48,246 - $80,956
40,887 Added 120.61%
74,786 $93,000
Q3 2020

Nov 16, 2020
SELL
$1.01 - $1.81 $44,231 - $79,267
-43,794 Reduced 56.37%
33,899 $48,000
Q2 2020

Aug 14, 2020
SELL
$1.03 - $1.69 $2,550 - $4,184
-2,476 Reduced 3.09%
77,693 $94,000
Q1 2020

May 15, 2020
SELL
$0.76 - $2.07 $121,326 - $330,454
-159,640 Reduced 66.57%
80,169 $95,000
Q4 2019

Feb 14, 2020
SELL
$1.66 - $2.4 $81,119 - $117,280
-48,867 Reduced 16.93%
239,809 $506,000
Q3 2019

Nov 14, 2019
BUY
$2.1 - $2.87 $130,158 - $177,882
61,980 Added 27.34%
288,676 $635,000
Q2 2019

Aug 16, 2019
BUY
$2.1 - $3.93 $133,274 - $249,413
63,464 Added 38.88%
226,696 $574,000
Q2 2019

Aug 14, 2019
SELL
$2.1 - $3.93 $838,469 - $1.57 Million
-399,271 Reduced 70.98%
163,232 $413,000
Q1 2019

May 15, 2019
BUY
$2.35 - $3.83 $79,608 - $129,745
33,876 Added 6.41%
562,503 $1.96 Million
Q4 2018

Feb 14, 2019
BUY
$2.13 - $4.8 $608,330 - $1.37 Million
285,601 Added 117.52%
528,627 $1.22 Million
Q3 2018

Nov 14, 2018
BUY
$2.6 - $4.6 $257,275 - $455,179
98,952 Added 68.68%
243,026 $936,000
Q2 2018

Aug 14, 2018
BUY
$2.13 - $4.2 $75,252 - $148,386
35,330 Added 32.49%
144,074 $486,000
Q1 2018

May 15, 2018
SELL
$1.7 - $2.35 $94,168 - $130,173
-55,393 Reduced 33.75%
108,744 $228,000
Q4 2017

Feb 14, 2018
SELL
$1.75 - $5.5 $108,764 - $341,830
-62,151 Reduced 27.47%
164,137 $333,000
Q3 2017

Nov 14, 2017
BUY
$2.9 - $4.6 $656,235 - $1.04 Million
226,288
226,288 $1.04 Million

About ACELRX PHARMACEUTICALS INC

ACRX Quotes by TradingView
  • Ticker ACRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 7,366,600
  • Market Cap $8.32M
  • Description
  • AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...
More about ACRX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email